HOME >> MEDICINE >> NEWS
Melanoma research receives a massive funding boost

NSW cancer researchers from the Sydney Melanoma Unit have received over $11 million to advance their world-leading research into the diagnosis and treatment of melanoma.

Australians have the highest rate of melanoma in the world, with incidence levels up to four times higher than the US and the UK, and up to ten times higher than most other countries.

Whilst it is the third most common cancer in Australia, it has proved to be one of the most difficult to manage. It most commonly affects those in the 30-45 year age group - people in the prime of their life- yet standard cancer treatments are often ineffective.

The Sydney Melanoma Unit is a group of cancer researchers and clinicians drawn from Westmead Millennium Institute, Newcastle Mater and Royal Prince Alfred Hospitals. It runs the largest melanoma treatment centre in the world, and with associated expertise in molecular diagnosis and treatment, provides our best hope for improving outcomes in people who develop, or are at risk of developing, melanoma.

This research group was recently recognised with a $3.75 million Program Grant from the Cancer Institute NSW. Today the Hon Tony Abbott, Commonwealth Minister for Health, announced that the Unit has also been awarded a prestigious National Health and Medical Research Council Program Grant, providing a further $7.8 million to support its vital research.

"Melanoma cells that have spread from their site of origin are notorious for being resistant to cancer treatment such as chemotherapy and radiotherapy" says Professor Richard Kefford, Chief Investigator of the successful Sydney Melanoma Unit NHMRC grant and researcher at Westmead Millennium Institute.

"These funds will allow us to progress our research into the molecular factors that determine an individual's risk of melanoma, so that we can identify the type of melanoma they have and how that disease will respond to treatments. We can then create more effective treatme
'"/>

Contact: Gayle McNaught
gayle_mcnaught@wmi.usyd.edu.au
61-298-459-009
Research Australia
6-Jul-2005


Page: 1 2

Related medicine news :

1. Summer update: Melanoma research progress suggests optimism for future cures
2. Melanoma vaccine strategy shows promise in laboratory experiments
3. Melanoma risk only partially associated vith exposure to UVB from sunlight
4. 1 of 2 pediatric kidney disease research centers in world established
5. Stanford researchers find culprit in aging muscles that heal poorly
6. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
7. Indiana University Imaging Center receives $6M grant for kidney research
8. Penn researchers discover novel pathway for increasing good cholesterol
9. New research discovers independent brain networks control human walking
10. Theory of facial aging gets a facelift from UT Southwestern researchers
11. Sports concussion research using fMRI provides insight for safe return-to-play decisions

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Melanoma research receives massive funding boost

(Date:10/31/2014)... (HealthDay News) -- A comparison of two of the ... laparoscopic gastric bypass helped patients shed more excess pounds ... of short-term complications and long-term hospitalizations. Gastric-bypass surgery ... so your body does not absorb all the calories ... of Health. Gastric banding is a type of weight-loss ...
(Date:10/31/2014)... By Steven Reinberg HealthDay ... skin condition eczema may increase slightly the risk of broken bones ... of 34,500 adults, researchers found that among 7 percent of people ... had a bone or joint injury and 0.6 percent had an ... people without eczema, those with the skin condition had more than ...
(Date:10/30/2014)... for injuries and damage to the joints, including articular ... a hard material that caps the ends of bones ... engineers, exploring ways to toughen up engineered cartilage and ... developments this week in the journal Proceedings of ... with engineered tissue is that the mechanical properties are ...
(Date:10/30/2014)... by NIH grantees predicts that women must take the ... vaginal sex, whereas just two doses per week can ... finding helps explain why two large clinical trials testing ... show efficacy. Participants in the VOICE and ... antiretroviral) for HIV prevention were counseled to take one ...
(Date:10/30/2014)... Don Allred Insurance, a leading provider ... for North Carolina residents, is excited to announce the ... Hill Mall. The new branch has been up and ... through all facets of the insurance selection process from ... Scott Allred couldn’t be happier with the timing of ...
Breaking Medicine News(10 mins):Health News:Study Compares 2 Common Weight-Loss Surgeries 2Health News:Study Compares 2 Common Weight-Loss Surgeries 3Health News:Eczema Tied to Bone Fracture Risk in Study 2Health News:Making lab-grown tissues stronger 2Health News:Model by NIH grantees explains why HIV prevention dosing differs by sex 2Health News:Allred Insurance Satellite Office Grand Opening 2
(Date:10/31/2014)... -- Encision Inc. (OTCQB:ECIA), a medical device company owning patented ... minimally invasive surgery, today announced financial results for its ... The Company posted quarterly net revenue of $2.279 ... or $(0.04) per share. These results compare to net ... $50 thousand, or $(0.01) per share, in the year-ago ...
(Date:10/31/2014)... October 30, 2014 ... the addition of the  "Process Validation in the ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,Key ... Risk Based Approach to Process Validation for Pharmaceutical ... FDA Process Validation Guidance ...
(Date:10/31/2014)... 2014  AbbVie (NYSE: ABBV ) ... ended Sept. 30, 2014. "Our ... business with double-digit growth from HUMIRA and several ... 14 percent in the quarter excluding lipids," said ... AbbVie.  "We exceeded our outlook for the quarter ...
Breaking Medicine Technology:Encision Reports Second Quarter Fiscal Year 2015 Results 2Encision Reports Second Quarter Fiscal Year 2015 Results 3Encision Reports Second Quarter Fiscal Year 2015 Results 4Encision Reports Second Quarter Fiscal Year 2015 Results 5Process Validation in the US and EU (Workshop, London) 2Process Validation in the US and EU (Workshop, London) 3Process Validation in the US and EU (Workshop, London) 4AbbVie Reports Third-Quarter 2014 Financial Results 2AbbVie Reports Third-Quarter 2014 Financial Results 3AbbVie Reports Third-Quarter 2014 Financial Results 4AbbVie Reports Third-Quarter 2014 Financial Results 5AbbVie Reports Third-Quarter 2014 Financial Results 6AbbVie Reports Third-Quarter 2014 Financial Results 7AbbVie Reports Third-Quarter 2014 Financial Results 8AbbVie Reports Third-Quarter 2014 Financial Results 9AbbVie Reports Third-Quarter 2014 Financial Results 10AbbVie Reports Third-Quarter 2014 Financial Results 11AbbVie Reports Third-Quarter 2014 Financial Results 12AbbVie Reports Third-Quarter 2014 Financial Results 13AbbVie Reports Third-Quarter 2014 Financial Results 14AbbVie Reports Third-Quarter 2014 Financial Results 15AbbVie Reports Third-Quarter 2014 Financial Results 16AbbVie Reports Third-Quarter 2014 Financial Results 17AbbVie Reports Third-Quarter 2014 Financial Results 18AbbVie Reports Third-Quarter 2014 Financial Results 19AbbVie Reports Third-Quarter 2014 Financial Results 20AbbVie Reports Third-Quarter 2014 Financial Results 21AbbVie Reports Third-Quarter 2014 Financial Results 22AbbVie Reports Third-Quarter 2014 Financial Results 23AbbVie Reports Third-Quarter 2014 Financial Results 24
Cached News: